Address: Wiedner Hauptstraße 90/12 . 1050 Wien . Österreich,Austria
Tel: +43 650 544 92 92
Web: http://www.generikaverband.at/
The Austria’s generics industry association, Österreichischer Generikaverband (OEGV), is a representative body of generic and biosimilar medicine suppliers in Austria. Its members are committed to the supply of medicines at affordable prices so that all patients have sustainable access to medicines. The OEGV members represents over 90 % of the generic and biosimilar pharmaceutical industry in Austria: Actavis GmbH, Dermapharm GmbH, Easypharm GmbH & Co KG, Genericon Pharma Gesellschaft m.b.H., G.L. Pharma GmbH, Hexal Pharma GmbH, Hospira Austria GmbH, interpharm ProduktionsgmbH, Pelpharma Handels GmbH, Sandoz GmbH, ratiopharm Arzneimittel VertriebsGmbH, S.MED GmbH, STADA Arzneimittel GmbH;
Formed in 2000 the association plays a vital role in the country’s health-care system and its economy by providing safe, effective, proven medicines.
Just like other European countries, Austria is in the search for meaningful savings in healthcare. Austria’s increasingly price sensitive pharma market is seeing the rise of generic medicines gaining market…
Barbara Fritsche-Surchat, general manager of Servier Austria, a leading innovative French company looking to bolster its global oncology presence, provides an in-depth analysis of the balancing act between pricing and…
Martin Spatz, country manager of QuintilesIMS Austria, the global leader in healthcare market research, discusses the diverse range of services they provide to the two separate entities of the of…
Rudolf Wessely, CEO and founder of Gynial, the Austrian leader in oral contraceptives, elaborates on the company’s incredibly fast market penetration since 2007 and explains his expertise in the contraceptive…
Bernhard Wittmann, managing director of Sigmapharm and MoNo, discusses the company’s product portfolio and the diverse tailored services for their partners. Furthermore, he provides an in-depth look into MoNo’s new…
Martin Tiani, CEO of Tiani Spirit, the global leader in Integrating the Healthcare Enterprise (IHE), discusses the importance of interoperability within electronic health information exchange (HIE) and the challenges e-health faces, especially…
Dr. Dietmar Katinger, CEO of Polymun, an Austrian R&D and contract manufacturing company, discusses the challenges CMO companies face within the Austrian market and increasing industry regulations. He also provides…
Like a family recipe that has been refined and perfected over countless generations, Austria has developed a reputation as the quintessential clinical trials destination; a perfect combination of world-class academia,…
Dr. Kurt Zatloukal, national node director of the Bio-Banking and Bio-Molecular Resources Research Infrastructure of Austria (BBMRI Austria), discusses the challenges of collaboration between the private and academic pharmaceutical sectors…
Dr. Daniel Wallerstorfer, CEO and founder of Novogenia, a vibrant Austrian genetics company, discusses founding his own company and the innovative services Novogenia provides to ensure genetics are a staple…
Günther Aschenbrenner, managing director of Théa Austria, a specialist French ophthalmology company, discusses the development of the company’s Austrian office since 2011 and how a strong portfolio acquired by Théa…
Daniela Homan, executive director of AmCham Austria, the representative and advocating voice of US companies in Austria, provides an in-depth analysis of the strategies being employed by the chamber and…
Karl Peter Schwarz, general manager of the Austrian affiliate of LEO Pharma, an ambitious Danish company leading the way in innovative dermatology treatments, provides an in-depth look into how global…
See our Cookie Privacy Policy Here
